BayonTech Focuses On mRNA And Covid Vaccine Production
BayonTech is focusing its operations on commercial mRNA manufacturing and Covid-19 vaccine production. The company stated that the transition in Marburg will occur without operational redundancies or layoffs.
Topics
Developing
- 893d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 892d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 892d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 892d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
hr-iNFO
“liegt auf der kommerziellen mRNA-Herstellung sowie auf dem Covid-Impfstoff. Die Kapazitäten sind Gewerkschaft Bergbau, Chemie und Energie, IGBCE, spricht von kurzfristigem finanziellen Kalkül. In Marburg soll es ohne betriebsbedingte Kündigungen gehen, sagt BayonTech.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade